Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
153
datasets available to search
ShareScore release 0.9.0
Dataset results
153 results for “Tobacco use”
Data for The impact of information about tobacco-related reproductive vs. general health risks on South Indian women's tobacco use decisions
<p>Tobacco Intervention Study Mysore India March-April 2016</p> <p>Published version: <a href="https://doi.org/10.1017/ehs.2020.61">https://doi.org/10.1017/ehs.2020.61</a></p>
eCEASE to Support Treatment for Parental Tobacco Use
ClinicalTrials.gov study NCT04974736. IPD Sharing: YES. Countries: 1. Publications: 1.
Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior
ClinicalTrials.gov study NCT04805515. IPD Sharing: YES. Countries: 1. Publications: 1.
Predicting Photosynthetic Capacity in Tobacco (Nicotiana tabacum) Using Shortwave Infrared Spectral Reflectance
<p>These files contains the data used for analysis in the (currently under-review) publication "<strong>Predicting Photosynthetic Capacity in Tobacco (</strong><strong><em>Nicotiana tabacum</em></strong><strong>) Using Shortwave Infrared Spectral Reflectance" </strong> in the Journal of Experimental Botany. </p>
Expression analysis of targeted genes Sgt1 (A) and Hsp90 (B) in tomato plants subjected to virus-induced gene silencing using Tobacco rattle virus (TRV) vector.
<p><strong>Figure S1</strong>. Expression analysis of targeted genes Sgt1 (A) and Hsp90 (B) in tomato plants subjected to virus-induced gene silencing using Tobacco rattle virus (TRV) vector. (A) Relative expression levels of Sgt1 analyzed by Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR) in tomato plants infected with TRV vector alone (TRV2), TRV carrying Sgt1 silencing constructs (TRV-Sgt1), and mock-inoculated (Mock). Transcript levels were normalized using tomato genes encoding elongation factor 1-α and SAND as internal references, with Mock as the calibrator. (B) Relative expression levels of Hsp90 analyzed by RT-qPCR in tomato plants infected with TRV2, TRV-Hsp90, and Mock. Gene expression levels were normalized using the same reference genes as in (A). (C) Quantification of the relative accumulation of TRV RNA in plants infected with TRV2 and in silenced plants (TRV-Sgt1 and TRV-Hsp90). The expression levels were normalized using tomato genes for elongation factor 1-α and SAND, with TRV2 as the calibrator. All samples were collected at 19 dpi to anticipate the observed decline. Error bars represent standard errors of five biological replicates, and an asterisk indicates a significant difference, as determined by one-way ANOVA with P < 0.05</p>
BeBOD estimates of attributable mortality and years of life lost due to tobacco use, 2013-2020
<h1>Belgian National Burden of Disease Study</h1> <h2>Estimates of the attributable burden of disease<strong><br></strong></h2> <p>Our results build on the estimates of causes of death from the <a href="https://www.sciensano.be/en/projects/belgian-national-burden-disease-study" target="_blank" rel="noopener">Belgian National Burden of Disease Study</a> and apply comparative risk assessment to estimate the proportion of that burden due to risk factors.</p> <h3>Population attributable fraction</h3> <p>Based on the estimated level of exposure and the associated health risk, a <strong>population attributable fraction (PAF)</strong> is calculated. The PAF is the proportion of the disease burden that is caused by exposure to the risk factor.</p> <h3>Attributable burden</h3> <p>The burden of disease is quantified in <strong>deaths</strong> and in <strong>Years of Life Lost (YLL)</strong>. To derive the burden attributable to a risk factor, its PAF is multiplied with the total observed burden.</p> <h2>Risk factors</h2> <h3>Tobacco use</h3> <p>The prevalence of never, former and current smokers, as well as the daily number of cigarettes smoked by smokers, is derived from the Belgian Health Interview Survey. Bayesian regression models are used to smoothen, interpolate and extrapolate observed estimates.</p> <h2>More information</h2> <p>For additional background on BeBOD, please visit <a href="https://www.sciensano.be/en/projects/belgian-national-burden-disease-study">https://www.sciensano.be/en/projects/belgian-national-burden-disease-study</a>.</p> <p>Explore the estimates via <a href="https://burden.sciensano.be/shiny/risk">https://burden.sciensano.be/shiny/risk</a>.</p>
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
ClinicalTrials.gov study NCT00939029. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches
ClinicalTrials.gov study NCT04812795. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Effects of Sedatives on Tobacco Use Disorder
ClinicalTrials.gov study NCT03813121. IPD Sharing: NO. Countries: 1. Publications: 0.
N-acetylcysteine for Tobacco Use Disorder
ClinicalTrials.gov study NCT02737358. IPD Sharing: YES. Countries: 1. Publications: 1.
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
ClinicalTrials.gov study NCT02233842. IPD Sharing: NO. Countries: 1. Publications: 2.
Advancing Tobacco Use Treatment for African American Smokers
ClinicalTrials.gov study NCT02360631. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy of Varenicline for Smokeless Tobacco Use in India
ClinicalTrials.gov study NCT01098305. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Reducing Tobacco Use Disparities Among Low-Income Adults
ClinicalTrials.gov study NCT03077737. IPD Sharing: NO. Countries: 1. Publications: 12.
Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use
ClinicalTrials.gov study NCT00717093. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Cannabis and Tobacco Co-use Study
ClinicalTrials.gov study NCT04228965. IPD Sharing: NO. Countries: 1. Publications: 1.
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
ClinicalTrials.gov study NCT04490057. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
ClinicalTrials.gov study NCT00218296. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fish Oil to Reduce Tobacco Use iN Expectant Mothers Study
ClinicalTrials.gov study NCT03077724. IPD Sharing: NO. Countries: 1. Publications: 2.
Project CheckUP: A Brief Behavioral Intervention for Quitline Callers Who Use Marijuana (MJ) and Tobacco
ClinicalTrials.gov study NCT04737772. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.